Zobrazeno 1 - 10
of 403
pro vyhledávání: '"Drug induced thrombocytopenia"'
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-5 (2024)
Abstract Background Nintedanib is a primary antifibrosing medication available for idiopathic pulmonary fibrosis, systemic sclerosis-interstitial lung disease, and progressive pulmonary fibrosis, with scattered report of drug-induced thrombocytopenia
Externí odkaz:
https://doaj.org/article/be806490f2a241eca771ade963d7902a
Publikováno v:
Hematology Reports, Vol 15, Iss 2, Pp 283-289 (2023)
A male in his 60s presented with left lower extremity fractures following a vehicle accident. Hemoglobin, initially, was 12.4 mmol/L, and platelet count was 235 k/mcl. On day 11 of admission, his platelet count initially dropped to 99 k/mcl, and afte
Externí odkaz:
https://doaj.org/article/e56b6116ab9c40f4b3481bd75134003a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
One of the major limitations in the clinical use of existing oxazolidinone antibiotics is their characteristic adverse reactions, in particular thrombocytopenia. In anti-infective treatment, if patients are suspected of having drug-induced thrombocyt
Externí odkaz:
https://doaj.org/article/1f5276d1c1e6433b873233dcfb9970bc
Autor:
Igor Dumic, Antonios Charokopos, Angadabir Parmar, Christopher R. Grant, Ronin Joshua S. Cosiquien, Marilia Dagnon da Silva, Emilia Petcu
Publikováno v:
Medicina, Vol 59, Iss 5, p 999 (2023)
Nintedanib is a tyrosine kinase inhibitor that was approved for the treatment of patients with idiopathic pulmonary fibrosis in 2014. The most common side effect of Nintedanib is diarrhea, and thrombocytopenia is a rare side effect of Nintedanib. The
Externí odkaz:
https://doaj.org/article/fd19f86c8e944c038669ece59658c461
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 11, Iss 2, Pp 269-272 (2021)
Eptifibatide is a glycoprotein (GP) IIb/IIIa receptor antagonist, used for the treatment of acute coronary syndrome with high-risk features or ongoing ischemia. Several case reports have described thrombocytopenia as a rare side effect of eptifibatid
Externí odkaz:
https://doaj.org/article/60b9a808fd4143c59580abca0aebc411
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xiaolu Nie, Lulu Jia, Xiaoxia Peng, Houyu Zhao, Yuncui Yu, Zhenping Chen, Liqiang Zhang, Xiaoling Cheng, Yaqi Lyu, Wang Cao, Xiaoling Wang, Xin Ni, Siyan Zhan
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Drug-induced thrombocytopenia (DITP) is a severe adverse reaction and a significantly under-recognized clinical problem in children. However, for post-marketing pharmacovigilance purposes, detection of DITP signals is crucial. This study
Externí odkaz:
https://doaj.org/article/1d95ab4d2f3e412ab7ef2fe0e21d3209
Publikováno v:
In Current Opinion in Toxicology October 2019 17:23-30
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 3, Pp 749-754 (2019)
Vancomycin induced thrombocytopenia (VIT) is an uncommon side effect of vancomycin which can manifest from mild petechiae to life-threatening bleed. Decreased renal clearance of vancomycin results in prolonged thrombocytopenia by antibody-mediated pl
Externí odkaz:
https://doaj.org/article/9771889757164be5a9a1d4be4731a2b7